DSpace at RU >

Browsing by Author Ananworanich, J.

Full Text	Issue Date	Title	Author(s)
	2011	Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children.	Bunupuradah, T.; Kosalaraksa, P.; Puthanakit, T.; Mengthaisong, T.; Wongsabut, J., et al
	2009	Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.	Lugt, J. van der; Gorowara, M.; Avihingsanon, A.; Burger, D.M.; Ananworanich, J., et al
	2009	Plasma concentrations of generic lopinavir/ritonavir in HIV type-1-infected individuals.	Lugt, J. van der; Lange, J.; Avihingsanon, A.; Ananworanich, J.; Sealoo, S., et al
	2009	Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks.	Bunupuradah, T.; Lugt, J. van der; Kosalaraksa, P.; Engchanil, C.; Boonrak, P., et al
	2009	Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children.	Puthanakit, T.; Lugt, J. van der; Bunupuradah, T.; Ananworanich, J.; Gorowara, M., et al
	2008	Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.	Kosalaraksa, P.; Bunupuradah, T.; Engchanil, C.; Boonrak, P.; Intasan, J., et al
	2006	Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals.	Bunupuradah, T.; Wannachai, S.; Chuamchaitrakool, A.; Intasan, J.; Nuchapong, T., et al
	2005	Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children.	Ananworanich, J.; Kosalaraksa, P.; Hill, A.; Siangphoe, U.; Bergshoeff, A.S., et al
	2004	Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.	Autar, R.S.; Ananworanich, J.; Apateerapong, W.; Sankote, J.; Hill, A., et al